Clinical Trials Browser

Phase 1/2 × Lymphoma × Other × Clear all

NCT03417765 2024-10-24

Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas

Phase 1/2 Withdrawn

Hodgkin Disease, Lymphoma, Mucositis

NCT00727831 2014-01-27

Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

Phase 1/2 Completed

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Neurotoxicity Syndromes, Mucositis